5014 G (Hydrochlorothiazide and spironolactone 25 mg / 25 mg)
Pill imprint 5014 G has been identified as Hydrochlorothiazide and spironolactone 25 mg / 25 mg.
Hydrochlorothiazide/spironolactone is used in the treatment of edema; nephrotic syndrome; high blood pressure; ascites; heart failure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/spironolactone 25 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 5014 G
- 25 mg / 25 mg
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Greenstone Limited
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium sulfate
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|54569-0502||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/spironolactone
- Hydrochlorothiazide and spironolactone
- Spironolactone and hydrochlorothiazide (Advanced Reading)
- Other brands: Aldactazide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.